{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-22-025724","form_type":"8-K","ticker":"ENVB","cik":"0000890821","company_name":"Enveric Biosciences, Inc.","filed_at":"2022-09-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:58.471199+00:00","generated_at":"2026-06-23T10:33:56.265869+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Enveric Biosciences appoints Robert Dickey IV as interim CFO effective Sept 9, 2022","bullets":["Robert Dickey IV, age 66, appointed as interim CFO effective September 9, 2022.","Mr. Dickey is Managing Director at Foresite Advisors, providing finance support for life science companies.","Previously served as CFO of Motif Bio Plc (2017-2018) and Tyme Technologies (2015-2017).","He holds an MBA from Wharton and a BA from Princeton."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-22-025724","json":"https://secwatch.observer/filing/0001493152-22-025724.json","markdown":"https://secwatch.observer/filing/0001493152-22-025724.md","text":"https://secwatch.observer/filing/0001493152-22-025724.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/890821/000149315222025724/0001493152-22-025724-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/890821/000149315222025724/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-23T10:33:56.265869+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"cc5dc37aba","claim":"Robert Dickey IV was appointed as Chief Financial Officer at Enveric Biosciences, Inc..","evidence_excerpt":"On September 9, 2022, Robert Dickey IV was appointed as the Chief Financial Officer (“CFO”) of the Company, to serve on an interim basis, effective September 9, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/890821/000149315222025724/0001493152-22-025724-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}